ESCR not a good investment

Embryonic stem cell research, regardless of the current presidential/congressional support, is in trouble. They have not figured out how to fix the problems (e.g. cancerous tumors), yet "adult" stem cells (e.g., from dental pulp, bone marrow, and fatty deposits) are consistently meeting or exceeding expectations. Motley Fool